Georgia
Provider Communications
BCBSGa expands specialty pharmacy prior authorization list
Effective for dates of service on and after September 1, 2018, the following specialty pharmacy codes from new or current medical policies or clinical UM guidelines will be included in our prior authorization review process.
BCBSGa’s prior authorization clinical review of these specialty pharmacy drugs will be managed by AIM Specialty Health® (AIM), a separate company.
The following clinical guidelines or medical policies will be effective September 1, 2018:
Medical Policy or Clinical Guideline |
|
Code |
|
Drug |
|
Comments |
CG-DRUG-44
|
|
J2507
|
|
Krystexxa®
|
|
Existing Guideline
|
CG-DRUG-89
|
|
J3490 Q9991 Q9992 |
|
Sublocade TM
|
|
New Drug to Existing Guideline |
Featured In:
June 2018 BCBSGa Provider Newsletter